Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2 - PubMed (original) (raw)

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

P H Hart et al. Proc Natl Acad Sci U S A. 1989 May.

Abstract

Stimulated human monocytes/macrophages are a source of mediators such as tumor necrosis factor alpha (TNF-alpha), interleukin 1 (IL-1), and prostaglandin E2 (PGE2), which can modulate inflammatory and immune reactions. Therefore, the ability to control the production of such mediators by monocytes/macrophages may have therapeutic benefits, and it has been proposed that glucocorticoids may act in this way. Purified human monocytes, when stimulated in vitro with lipopolysaccharide (LPS) or with LPS and gamma interferon (IFN-gamma), produce TNF-alpha, IL-1, and PGE2. Cotreatment of stimulated cells with the purified human lymphokine, interleukin 4 (IL-4 greater than or equal to 0.1-0.5 unit/ml; 12-60 pM) dramatically blocked the increased levels of these three mediators; for TNF-alpha and IL-1, the inhibition was manifest at the level of mRNA. Thus, IL-4 can suppress some parameters of monocyte activation and, as for B cells, have opposite effects to IFN-gamma. The effects of IL-4 on human monocytes are similar to those obtained with the glucocorticoid dexamethasone (0.1 microM).

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1988 Mar 1;140(5):1548-54 - PubMed
    1. J Immunol. 1988 Mar 1;140(5):1542-7 - PubMed
    1. Immunol Lett. 1987 Dec;16(3-4):227-31 - PubMed
    1. J Biol Chem. 1988 Apr 15;263(11):5380-4 - PubMed
    1. J Immunol. 1988 Apr 15;140(8):2625-32 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources